Mycobacterium tuberculosis causes tuberculosis Tuberculosis : an infectious disease affects the lungs, but can also affect other parts of the body. It is the most common cause of infectious disease–related mortality. Morphology of M. tuberculosis slightly curved thin rod-shaped bacilli. Non-sporing, non-motile, non-capsulated bacteria. Acid-fast bacilli Gram +ve During acid-fast stain, they appear bright red to intensive purple with green/blue background. They measure 0.5 µm x 3 µm. Appears in single, in pairs, or small chumps. The high content of mycolic acid (50 to 60 %). The cell wall is rich in lipids and waxes. A. Lipids Mycobacteria are rich in lipids. These include mycolic acids and waxes. B-proteins That produce the tuberculin reaction. C-Polysaccharides They residecolorization by acid or alcohol so called acid fast bacilli when infected persons cough, sneeze, or speak.
Mycobacteria are secreted in droplets
organisms are set down in alveoli.
One to 2 months after exposure,
infection appear in the lung. RISK FACTOR A healthy immune system can often successfully fight TB bacteria, but your body can't mount an effective defense if your resistance is low. HIV/AIDS Diabetes Chemotherapy Malnutrition Advanced age Alcoholism Immunosuppressive medications 1-Fatigue 2- chronic cough spitting of blood . 3-weight loss 4- fever and night sweats Is tuberculosis(TB) within a location other than the lungs. This occurs in 15–20% of active cases, Extrapulmonary TB occurs more commonly in immunosuppressed persons and young children. Examples on Extrapulmonary tuberculosis : Gastrointestinal tuberculosis Tuberculous meningitis Urogenital tuberculosis Bones and joints tuberculosis 1-Chest X-ray and CT
2-Smear for Microscopy
Sputum is examined for acid-fast bacilli by Ziehl-Neelsen staining A standard dose of 5 tuberculin units (TU - 0.1 ml), is injected intradermally and read 48 to 72 hours later. An infected person is expected to mount an immune response in the skin containing the bacterial proteins. A selective agar media (eg Löwenstein-Jensen ) Incubation is at 35–37°C in 5–10% CO2 for up to 8 weeks. Treatment continued for six months: 1- Isoniazide (INH) 2-Rifampicin. 3-pyrazinamide 4-ethambutol